Posts by tag
targeted therapies
Making Sense of a Decade of Progress in Advanced Breast Cancer: ABC8, Lisbon 2025
The 8th ABC International Consensus Conference (ABC8), Lisbon 2025 Over the past decade, the landscape of advanced breast cancer has changed more rapidly than at any time since systemic therapy became standard. New drug classes, more refined biomarkers, and increasingly…
Surviving the Tumor, Living with the Impact
“When this tumor entered our lives, nothing felt stable anymore — we had to rebuild our days piece by piece," a caregiver recalls. Why brain cancer survivorship needs to move center stage — as research pushes into AI, precision medicine…
Molecular tumour boards: translating data into tailored therapeutics
Developments in molecular diagnostics are allowing us to capture an extraordinarily detailed picture of the genomic and other molecular changes that characterise a given tumour specimen. But making best use of the information at our disposal is proving quite a…
Oncolytic viruses – a new wave of therapeutic possibilities
Going back to the nineteenth century there were reports that infectious diseases seemed to provide brief periods of remission for cancer patients. One case from 1896 reported that the enlarged spleen of a woman with “myelogenous leukemia” shrank to nearly…
Right drug, wrong patient: here’s how we improve our targeting
When it comes to precision and personalised medicine (PPM), clinical practice in oncology takes pride in developing and administering treatments that selectively target components of tumour cells. But, PPM is a model that also takes into account the inherent variability…